[HTML][HTML] Cavitating pulmonary tuberculosis: a global challenge

W Saeed - Clinical medicine, 2012 - ncbi.nlm.nih.gov
Tuberculosis (TB) remains a major challenge and burden on healthcare with devastating
fallout. The World Health Organization (WHO) has declared it a 'global emergency'. In the …

Cavitating pulmonary tuberculosis: a global challenge

G Bothamley, M Lipman, OM Kon - Clinical Medicine, 2012 - rcpjournals.org
Editor–We were concerned that a new treatment for tuberculosis (TB) was being advocated
without the benefit of a randomised controlled trial (W Saeed, Clin Med February 2012 pp 40 …

[HTML][HTML] Outcomes of extended duration therapy for drug-susceptible cavitary pulmonary tuberculosis

H Lee, JW Sohn, YS Sim, TR Shin… - Annals of Translational …, 2020 - ncbi.nlm.nih.gov
Background Extending the continuation phase treatment duration is recommended to
improve outcomes of drug-susceptible cavitary pulmonary tuberculosis (TB), but limited data …

[HTML][HTML] Clinical factors associated with cavitary tuberculosis and its treatment outcomes

SH Kim, YM Shin, JY Yoo, JY Cho, H Kang… - Journal of personalized …, 2021 - mdpi.com
Cavitary pulmonary tuberculosis (TB) is associated with poor outcomes, treatment
recurrence, higher transmission rates, and the development of drug resistance. However …

[HTML][HTML] The value of initial cavitation to predict re-treatment with pulmonary tuberculosis

Q Huang, Y Yin, S Kuai, Y Yan, J Liu, YY Zhang… - European journal of …, 2016 - Springer
Objective Pulmonary cavitation is the classic hallmark of pulmonary tuberculosis (PTB) and
is the site of very high mycobacterial burden associated with antimycobacterial drug …

Cavitary tuberculosis: the gateway of disease transmission

ME Urbanowski, AA Ordonez… - The Lancet Infectious …, 2020 - thelancet.com
Tuberculosis continues to be a major threat to global health. Cavitation is a dangerous
consequence of pulmonary tuberculosis associated with poor outcomes, treatment relapse …

Risk factors for pulmonary cavitation in tuberculosis patients from China

L Zhang, Y Pang, X Yu, Y Wang, J Lu… - Emerging microbes & …, 2016 - Taylor & Francis
Pulmonary cavitation is one of the most frequently observed clinical characteristics in
tuberculosis (TB). The objective of this study was to investigate the potential risk factors …

[HTML][HTML] A case report of persistent drug-sensitive pulmonary tuberculosis after treatment completion

SA Vashakidze, A Chandrakumaran, M Japaridze… - BMC Infectious …, 2022 - Springer
Abstract Background Mycobacterium tuberculosis (Mtb) has been found to persist within
cavities in patients who have completed their anti-tuberculosis therapy. The clinical …

Is the Beijing strain of Mycobacterium tuberculosis associated with cavitary lung disease?

HJ Chapman, SA Phillips, JL Hosford… - Infection, Genetics and …, 2015 - Elsevier
We conducted a cross-sectional study to describe clinical characteristics of patients with
pulmonary tuberculosis with and without evidence of pulmonary cavitation on chest …

[HTML][HTML] Proposed approach for 4-month treatment of culture-negative pulmonary tuberculosis in adults

Y Hamada, L Paulos, NG Baruch… - Annals of the American …, 2016 - atsjournals.org
Standard treatment for pan-sensitive pulmonary tuberculosis (TB) includes a 2-month initial
phase of isoniazid (H), rifampicin (R), pyrazinamide (Z), and ethambutol (E) followed by a 4 …